Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E E Fortess

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The Milbank Quarterly|January 1, 1993
A critical analysis of studies of state drug reimbursement policies: research in need of disciplineS B Soumerai, D Ross-Degnan, E E Fortess, et al.
JAMA|October 27, 1993
Examining product risk in context. Market withdrawal of zomepirac as a case studyD Ross-Degnan, S B Soumerai, E E Fortess, et al.
Journal of the American Geriatrics Society|July 17, 2001
Utilization of essential medications by vulnerable older people after a drug benefit cap: importance of mental disorders, chronic pain, and practice settingE E Fortess, S B Soumerai, T J McLaughlin, et al.
The Milbank Quarterly|January 1, 1997
Determinants of change in Medicaid pharmaceutical cost sharing: does evidence affect policy?S B Soumerai, D Ross-Degnan, E E Fortess, et al.
The American Journal of Sports Medicine|March 1, 1987
Medical and physiological considerations in triathlonsW D Hiller, M L O'Toole, E E Fortess, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The Milbank Quarterly|January 1, 1993
A critical analysis of studies of state drug reimbursement policies: research in need of disciplineS B Soumerai, D Ross-Degnan, E E Fortess, et al.
JAMA|October 27, 1993
Examining product risk in context. Market withdrawal of zomepirac as a case studyD Ross-Degnan, S B Soumerai, E E Fortess, et al.
Journal of the American Geriatrics Society|July 17, 2001
Utilization of essential medications by vulnerable older people after a drug benefit cap: importance of mental disorders, chronic pain, and practice settingE E Fortess, S B Soumerai, T J McLaughlin, et al.
The Milbank Quarterly|January 1, 1997
Determinants of change in Medicaid pharmaceutical cost sharing: does evidence affect policy?S B Soumerai, D Ross-Degnan, E E Fortess, et al.
The American Journal of Sports Medicine|March 1, 1987
Medical and physiological considerations in triathlonsW D Hiller, M L O'Toole, E E Fortess, et al.
Pageof 1